Literature DB >> 7476201

GvpCs with reduced numbers of repeating sequence elements bind to and strengthen cyanobacterial gas vesicles.

R Kinsman1, A E Walsby, P K Hayes.   

Abstract

We have previously shown that the gas-vesicle protein GvpC is present on the outer surface of the gas vesicle, can be reversibly removed and rebound to the surface, and increases the critical collapse pressure of the gas vesicle. The GvpC molecule, which contains five partially conserved repeats of 33 amino acids (33-RR) sandwiched between 18 N-terminal and 10 C-terminal amino acids, is present in a ratio of 1:25 with the GvpA molecule, which forms the ribs of the gas vesicle. By using recombinant techniques we have now made modified versions of GvpC that contain only the first two, three or four of the 33-amino-acid repeats. All of these proteins bind to and strengthen gas vesicles that have been stripped of their native GvpC. Recombinant proteins containing three or four repeats bind in amounts that give the same ratio of 33-RR:GvpA (i.e. 1:5) as the native protein, and they restore much of the strength of the gas vesicle; the protein containing only two repeats binds at a lower ratio (1:7.7), however, and restores less of the strength. Ancestral proteins with only two, three or four of the 33-amino-acid repeats would have been functional in strengthening the gas vesicle but the progressive increase in number of repeats would have provided strength with increased efficiency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7476201     DOI: 10.1111/j.1365-2958.1995.mmi_17010147.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  10 in total

1.  Molecular Engineering of Acoustic Protein Nanostructures.

Authors:  Anupama Lakshmanan; Arash Farhadi; Suchita P Nety; Audrey Lee-Gosselin; Raymond W Bourdeau; David Maresca; Mikhail G Shapiro
Journal:  ACS Nano       Date:  2016-06-30       Impact factor: 15.881

2.  Haloarchaeal gas vesicle nanoparticles displaying Salmonella antigens as a novel approach to vaccine development.

Authors:  P DasSarma; V D Negi; A Balakrishnan; J-M Kim; R Karan; D Chakravortty; S DasSarma
Journal:  Procedia Vaccinol       Date:  2015

Review 3.  Distribution, formation and regulation of gas vesicles.

Authors:  Felicitas Pfeifer
Journal:  Nat Rev Microbiol       Date:  2012-09-03       Impact factor: 60.633

4.  Eight of fourteen gvp genes are sufficient for formation of gas vesicles in halophilic archaea.

Authors:  S Offner; A Hofacker; G Wanner; F Pfeifer
Journal:  J Bacteriol       Date:  2000-08       Impact factor: 3.490

5.  The gas vesicle gene cluster from Microcystis aeruginosa and DNA rearrangements that lead to loss of cell buoyancy.

Authors:  Alyssa Mlouka; Katia Comte; Anne-Marie Castets; Christiane Bouchier; Nicole Tandeau de Marsac
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

6.  Functional studies of the gvpACNO operon of Halobacterium salinarium reveal that the GvpC protein shapes gas vesicles.

Authors:  S Offner; G Wanner; F Pfeifer
Journal:  J Bacteriol       Date:  1996-04       Impact factor: 3.490

Review 7.  Gas Vesicle Nanoparticles for Antigen Display.

Authors:  Shiladitya DasSarma; Priya DasSarma
Journal:  Vaccines (Basel)       Date:  2015-09-07

8.  An improved genetic system for bioengineering buoyant gas vesicle nanoparticles from Haloarchaea.

Authors:  Shiladitya DasSarma; Ram Karan; Priya DasSarma; Susan Barnes; Folasade Ekulona; Barbara Smith
Journal:  BMC Biotechnol       Date:  2013-12-21       Impact factor: 2.563

9.  Interaction of the gas vesicle proteins GvpA, GvpC, GvpN, and GvpO of Halobacterium salinarum.

Authors:  Alisa Jost; Felicitas Pfeifer
Journal:  Front Microbiol       Date:  2022-07-29       Impact factor: 6.064

10.  The model cyanobacteria Anabaena sp. PCC 7120 possess an intact but partially degenerated gene cluster encoding gas vesicles.

Authors:  Kun Cai; Bo-Ying Xu; Yong-Liang Jiang; Ying Wang; Yuxing Chen; Cong-Zhao Zhou; Qiong Li
Journal:  BMC Microbiol       Date:  2020-05-06       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.